0001209191-15-072818.txt : 20151001 0001209191-15-072818.hdr.sgml : 20151001 20151001173942 ACCESSION NUMBER: 0001209191-15-072818 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150930 FILED AS OF DATE: 20151001 DATE AS OF CHANGE: 20151001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 151137968 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-30 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2015-09-30 4 M 0 10400 35.64 A 355684 D Common Stock 2015-09-30 4 S 0 3700 102.24 D 351984 D Common Stock 2015-09-30 4 S 0 4040 103.20 D 347944 D Common Stock 2015-09-30 4 S 0 2260 104.15 D 345684 D Common Stock 2015-09-30 4 S 0 400 105.13 D 345284 D Common Stock 13286 I 401(k) Common Stock 122700 I Common Stock held in trust Stock Option (right to buy) 35.64 2015-09-30 4 M 0 10400 0.00 D 2016-02-01 Common Stock 10400 177600 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $102.24 (range $101.74 to $102.72). Open market sales reported on this line occurred at a weighted average price of $103.20 (range $102.74 to $103.73). Open market sales reported on this line occurred at a weighted average price of $104.15 (range $103.76 to $104.75). Open market sales reported on this line occurred at a weighted average price of $105.13 (range $105.11 to $105.16). Fully vested. Omar White, Attorney-In-Fact 2015-10-01